. Survey of methodological controls in immunocapture and immunoblotting studies. Studies employing immunoblotting , immunoprecipitation, and immunoaffinity purificationtechniques most directly analogous to the methods used in the current paper-were surveyed. Four searches were conducted in PubMed: 1) search designed to capture such studies in the field of Alzheimer's research conducted during the preceding year; 2) search designed to capture studies related to β-amyloid oligomers, the specific subject of our own research that led to the identification of the artefacts described in the current paper; 3) more focused search to find papers that may have used a biotin amplification system when immunologically characterizing amyloid peptides; and 4) search designed to find any papers that employed a biotin amplification system in immunoblotting studies more generally, conducted during the preceding year. These searches yielded a total of 751 studies to which we had access to the full text. Of these, 230 were excluded-primarily because they did not include an appropriate immunoblotting or immunocapture technique. Of the remaining 521 studies, only 56 (< 11 percent) mentioned a methodological control for the immunoblotting or immunocapture experiment (as opposed to a control for experimental condition-e.g., disease vs. healthy control, drug treated vs. vehicle-treated animal, cells transfected with coding DNA vs empty vector). Search dates are shown in parentheses, and the number of papers returned by each search is shown in bold. Detection methods for immunoblots are shown: HRP-conjugated secondary antibody, HRP-conjugated secondary antibody followed by chemiluminescent reagent; Unspecified ECL, chemiluminescent reagent (peroxidase substrate) with unspecified HRP-conjugated detection reagent; Biotin … HRP, biotin-avidin-HRP amplification followed by chemiluminescent reagent; Infrared, detection reagent conjugated to infrared dye; Other, alkaline phosphatase-or fluorophore-conjugated detection reagents; Unknown, citations provided but detailed methods not provided within paper. ECL, enhanced chemiluminescence; IP, immunoprecipitation or immunoaffinity purification; ICC, immunocytochemistry; IHC, immunohistochemistry.
